News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3127last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
24/7 Wall St.46d agoneutral
4 Elite Dividend Stocks Yielding Up to 6.14% With Diversified Pipelines That Protect Your PayoutBioPharma Dive47d agoneutral
An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slideSimply Wall St.47d agoneutral
What Johnson & Johnson (JNJ)'s Bipolar I Mania Data for CAPLYTA Means For ShareholdersSimply Wall St.47d agoneutral
What Could Johnson & Johnson (JNJ) Gain From Its New Immunology Push?Clinical Trials Arena47d agobullish
J&J’s Intra-Cellular buy continues to bear fruit with Caplyta bipolar winMotley Fool48d agoneutral
Does Long-Term Dividend Investing Really Work? This Study Says "Definitely."Simply Wall St.51d agoneutral
PepsiCo (PEP) Adds A New Director, Is The Discount To Fair Value Warranted?